Heart Failure V: Medical Management

Position the patient in high Fowler's position and continuously monitor ECG, oxygen saturation, and hemodynamic parameters including arterial blood pressure. Provide supplemental oxygen to increase PaO2, or use mechanical ventilation for severe pulmonary edema. Administer diuretics like furosemide and vasodilators such as nitroglycerin to reduce preload and afterload, relieving symptoms and optimizing volume status.

Diuretics like furosemide promote sodium and water excretion, reducing preload and pulmonary congestion. Vasodilators such as nitroglycerin reduce both preload and afterload by relaxing blood vessels. Together, these medications decrease the workload on the heart, improve left ventricular function, and relieve dyspnea in patients with acute decompensated heart failure.

Positive inotropes like dobutamine enhance myocardial contractility and increase cardiac output in patients with low cardiac output. These beta-agonists improve the heart's pumping ability during acute decompensated heart failure, helping maintain end-organ perfusion and supporting hemodynamic stability when the heart cannot generate adequate force.

ACE inhibitors like lisinopril and angiotensin II receptor blockers like losartan are first-line medications that reduce afterload and slow ventricular remodeling. Diuretics like furosemide manage fluid overload. The combination of isosorbide dinitrate and hydralazine provides additional vasodilation. These therapies address underlying causes, enhance cardiac output, and improve quality of life in chronic heart failure.

Digitalis, or digoxin, acts as a weak positive inotrope and neurohormonal modulator, reducing renin secretion and sympathetic nervous system effects. This helps modulate the body's compensatory responses to heart failure, improving cardiac function and reducing symptoms in patients with chronic heart failure who require additional neurohormonal regulation.

Supplemental oxygen improves blood oxygenation and reduces dyspnea and fatigue. Physical and emotional rest conserves energy and decreases oxygen demand on the heart. Continuous pulse oximetry monitoring assesses oxygen therapy effectiveness. These measures, combined with medications, help manage symptoms, preserve organ function, and improve quality of life in chronic heart failure patients.

Continuous ECG and oxygen saturation monitoring, along with hemodynamic assessments of arterial blood pressure and urine output, allow clinicians to detect changes in cardiac status and adjust therapies to maximize cardiac output and reduce pulmonary artery wedge pressure. Regular monitoring ensures optimal treatment response and prevents complications in unstable patients requiring intensive care.